Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "MammaPrint Index as a Predictive Biomarker for Neoadjuvant Chemo Response & Outcome in Patients With HR+/HER2- BC in NBRST"

239 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login